SaudiVax intends to be the premier developer, manufacturer, and supplier of vaccines and biologics in Saudi Arabia and the MENA region, including…

Amid global supply shortages and shipment delays for COVID-19 vaccines, South Korea has launched an ambitious 2.2 trillion won (USD 1.9 billion)…

A roundup of the latest from Chinese pharma, including Green Valley's upcoming US trial for an Alzheimer's drug inspired by algae; Samsung Biologics…

The Chinese healthcare market has transformed dramatically in the past few years. There have been many reforms centred around the country’s vision…

The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in…

It was less than a decade ago (2011) that Samsung BioLogics was a new kid on the block amongst Korea’s booming biotech conglomerates. Since then…

Young-Woo Park, CEO of Y-Biologics - renowned for their library with diversity of 1011 - unveils their plan to be the first in Korea to develop the…

Geoffrey Guy, David Meek, Tae Han Kim, Pierre Moustial, Vivek Sharma, Antonio Portela and many other remarkable people that are shaping the global…

In an exclusive interview, Tae-Han Kim, president and CEO of Samsung Biologics, documents his strategy for expanding Samsung’s operations into…

Chief Executive since 2011, Peter Coleman introduces Cobra Biologics and highlights challenges both domestically and globally in the biotech space for…

Osamu Nagayama, president of the Japan BioIndustry Association (JBA) and chairman and CEO of Chugai Pharmaceutical, discusses Japan’s footprint in…

Stefan Larson, CEO of Northern Biologics, explains the major milestones for Northern Biologics over the past three years, his personal motivation for…